ClinicalTrials.gg
Sign In

Pseudophakia clinical trials

The registry lists 54 studies for Pseudophakia across more than 10 countries. 8 are recruiting or about to start. 22 of them are mainly about Pseudophakia (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-25.

Get an email when these change. Save the Pseudophakia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
33
Status unknown
9
Recruiting
3
Enrolling by invitation
3
Not yet recruiting
2
Withdrawn
2

Phase

Phase 4
8
Phase 3
2
Phase 1
1
Phase 2
1
Early Phase 1
1

Where

United States
16
Austria
6
United Kingdom
5
Kosovo
4
Brazil
3
Hungary
3

Who runs them

Medicontur Medical Engineering Ltd (4) · Eye Hospital Pristina Kosovo (4) · Berkeley Eye Center (4) · Medical University of Vienna (3) · Brighton and Sussex University Hospitals NHS Trust (3) · Vance Thompson Vision (2) · Toyos Clinic (2) · Vienna Hospital Association (2)

What is being tested here

Drugs under test in Pseudophakia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Bromfenac001
Hypromellose Derivatives001
Carboxymethylcellulose001
Dexamethasone phosphate001
Dexamethasone001
Aflibercept001
Brimonidine001
Pilocarpine001
Prednisolone acetate001
Prednisolone001

Coming up

0phase 3 studies under way
3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Who these studies take

Of the 3 Pseudophakia studies recruiting now, 2 (67%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (67%) take healthy volunteers.

Recruiting studies that take each age, of 3
AgeWomenMen
100 (0%)0 (0%)
180 (0%)0 (0%)
302 (67%)2 (67%)
403 (100%)3 (100%)
503 (100%)3 (100%)
653 (100%)3 (100%)
753 (100%)3 (100%)
852 (67%)2 (67%)

Across all 54 studies, recruiting or not: 9% stop at 75 or younger and 6% at 65; 4% take children; 0% are for women only and 0% for men only; 33% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Pseudophakia studies take

Of 16 observational studies under Pseudophakia, half reached primary completion within 10 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Observational10 mo4–16 · 16 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 54. Browse all 54 → or search them.